Abstract
Hepatocellular carcinoma (HCC) is among the most prevalent and lethal cancers worldwide. Chitosan-coated iron oxide nanocomposite (Fe3O4/Cs) is a promising bio-nanomaterial for many biological applications. The objective of this research was to evaluate the anticancer efficacy of Fe3O4/Cs against HCC in animal models. Fe3O4 nanoparticles were prepared and added to chitosan solution; then, the mixture was exposed to gamma radiation at a dose of 20 kGy. Rats have received diethylnitrosamine (DEN) orally at a dose of 20 mg/kg body weight 5 times per week during a period of 10 weeks to induce HCC and then have received Fe3O4/Cs intraperitoneal injection at a dose of 50 mg/kg body weight 3 times per week during a period of 4 weeks. After the last dose of Fe3O4/Cs administration, animals were sacrificed. DEN induced upregulation of PI3K/Akt/mTOR and MAPK (ERK, JNK, P38) signaling pathways and inflammatory markers (TLR4, iNOS, and TNF-α). DEN also decreases cleaved caspase-3 and increases liver enzymes (ALT, AST, and GGT) activities. Administration of Fe3O4/Cs significantly ameliorated the above-mentioned parameters.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer and the fourth highest cause of cancer-related death worldwide [1]. HCC usually with poor prognosis. Over the previous few decades, the number of people diagnosed with HCC and dying from it has grown. Advanced HCC, on the other hand, has very few therapy choices [2]. Chemotherapy is the most common traditional cancer treatment, rather than local lesions that can be treated with surgery or radiotherapy. Anticancer medications, on the other hand, come with many negative side effects. Each medicine has its own set of side effects that might lead to patient noncompliance and a decline in quality of life. The production of reactive oxygen species (ROS) is one of the most common causes of unfavorable responses [3].
Recent advances in nanotechnology have provided a plethora of methods for fighting cancer with novel and effective therapeutic agents that avoid the drawbacks that standard medications have. Nanomaterials have been used as cancer therapeutics due to their ability to modulate autophagy [4]. Many research findings have shown that nanomaterials, particularly metallic nanoparticles, could be used to treat cancer by promoting a variety of events such as mitochondrial damage, lysosome impairment, endoplasmic reticulum stress, and signalling pathway alterations, which all result in mitophagy stimulation, oxidative stress, and autophagic cell death. Importantly, as compared to noncancerous cells, metallic nanoparticles have shown intrinsic selectivity in triggering autophagy in cancer cells. Metal-based nanomaterials, on the other hand, may play conflicting roles in cell fate, inducing pro-survival autophagy in both cancer and normal cells [5,6,7]. As a result, inhibiting autophagy could be a realistic strategy for improving cancer therapy efficacy. Magnetic iron oxide nanoparticles (Fe3O4 NPs) are a type of multifunctional nanomaterial that is increasingly being used in a variety of biomedical fields, such as magnetic resonance imaging, magnetic hyperthermia, magnetic targeting, magnetic separation, biological catalysis, photo-responsive therapy, and drug delivery. They are currently widely used in tumor diagnosis and treatment [8]. Because of its low toxicity in biological systems, iron oxide nanoparticles have shown considerable promise in biomedical applications. Iron oxide nanoparticles’ magnetic and semiconductor characteristics may also lead to multifunctional medical uses [9]. Other advantages of Fe3O4 NPs include prolonged blood circulation, rapid clearance, low side effects, good imaging, and therapeutic efficacy [10]. The key advantage of these nanoparticles over conventional drug delivery systems is their excellent biodistribution in the body [9]. Furthermore, Fe3O4 NPs have catalytic activity similar to peroxidase and have been proposed as a mimic enzyme for cancer therapy via the well-known Fenton reactions, which can catalyse endogenous hydrogen peroxide (H2O2) into the hydroxyl radical (•OH) with high cytotoxicity and cause tumor cell death [11].
Chitosan is reported to have a high biodegradability, biocompatibility, and stability, as well as minimal toxicity and immunogenicity in cells [12]. Chitosan is also a mucoadhesive cationic polymer that has been used widely in recent years to deliver anticancer chemotherapeutics to tumor cells [13]. Chitosan’s amine group will promote solubility and hemocompatibility in the intracellular environment [12]. Furthermore, the positive surface of nanoparticles will interact with many cellular components, which is a characteristic of chitosan, resulting in a longer connection between the encapsulated component and the cells. The presence of chitosan on the particle surface may also aid in the opening of tight intracellular junctions, thereby increasing cellular absorption and hence therapeutic efficiency [14, 15]. Fe3O4/Cs has potentially better biomedical properties than uncoated Fe3O4 NPs; thus, it is a promising bio-nanomaterial for many biological applications [16].
The actions of the phosphatidylinositol 3 kinase/kinase Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathways trigger autophagy. mTOR is a master regulator of cellular metabolism that responds to a variety of extracellular cues such as nutrition, growth hormones, and stress [17]. Its signalling pathway starts with insulin-activating PI3K, then moves on to Akt, which then activates mTOR [18]. Changes in cellular pathway proteins like PI3K/Akt/mTOR and MAPK/ERK, which are extensively dysregulated in malignant tumors, also support malignant cells’ ability to avoid apoptotic death and contribute to chemotherapy resistance [19]. Various types of NPs have been found to influence components in the mTOR signalling pathway and other related pathways, such as the AMPK and ERK pathways [20].
Towards this purpose, Fe3O4/Cs was successfully prepared and evaluated as anticancer against HCC in animal models.
Material and Methods
Materials
Diethylnitrosamine (DEN) purchased from Sigma-Aldrich (cat# N0756, St. Louis, MO, USA). Chitosan, ferrous chloride tetrahydrate (FeCl2. 4H2O), ferric chloride hexahydrate (FeCl3. 6H2O), and A sodium hydroxide (NaOH) were purchased from Merck. All chemicals were guaranteed or analytic grade reagents commercially available and used without further purification.
Preparation of Fe3O4 Nanoparticles Coated with Chitosan
Fe3O4 nanoparticles were prepared by co-precipitating the Fe3 + and Fe2 + ions by, firstly, dissolving 4 gm of (FeCl3. 6H2O) and 2 gm of (FeCl2. 4H2O) in 200 ml of doubly distilled water by vigorous stirring on magnetic stirrer; then 200 ml of sodium hydroxide (0.5 M) was added drop wisely and very slowly under stirring and heating to 80 °C until complete precipitation obtained [21]. Heating was continued at 80°for another 30 min, and then dispersion of formed magnetic nanoparticles washed several times with water by decantation to remove any excess sodium hydroxide. One hundred milliliter of the prepared Fe3O4 nanodispersion was added to 100 ml of chitosan solution at a concentration of 1% wt/v and vigorously stirred under heating at 80 °C for 1 h; then the mixture exposed to gamma radiation at a dose of 20 kGy. The formed magnetic nanoparticles that coated with chitosan exposed to gamma radiation to initiate partial degradation of chitosan chains and to facilitate the coating process of Fe3O4 NPs by chitosan.
Characterizations of Fe3O4/Chitosan Nanodispersions
Transmission Electron Microscopy (TEM)
TEM was used to observe the morphology (size and shape) of the formed magnetic nanoparticles. A drop of the resultant dispersion of magnetic nanoparticles mixture was deposited on an ultrathin carbon supported Cu grid and air-dried. Energy-filtered electron powder diffraction used TEM JEOL: JEM-100cx.
The X-Ray Diffraction (XRD)
The XRD analysis was performed using XD-DI Series, Shimadzu apparatus using nickel-filtered and Cu-K target, available in NCRRT.
Determination of the Median Lethal Dose (LD50) of Fe3O4/Cs
Fe3O4/Cs were given intraperitoneally to male albino rats in doses ranging from 50 to 700 mg/kg. Mortality after 24 h was registered.
The LD50 of Fe3O4/Cs was calculated according to the formula [22].
where Dm is the minimum dose which kills all animals in the group; Z is the mean of dead animals in two successive groups; d is the constant factor between two successive groups; n is the number of animals of each group; and Σ is the sum of (Zxd).
Experimental Design
Animal Groups
Twenty-four male albino rats (weighing 120–150 g at the start of the experiment) were randomly divided into 4 groups (6 animals/group):
-
Group 1 (Control): Healthy animals do not receive any treatment.
-
Group 2 (DEN): Rats were received diethylnitrosamine (DEN) orally at a dose of 20 mg/kg body weight, five times a week during a period of 10 weeks [23].
-
Group 3 (Fe3O4/Cs): Rats were received 50 mg/kg body weight of chitosan-coated iron oxide nanocomposite (Fe3O4/Cs) suspended in distilled water by intraperitoneal injection three times a week during a period of 4 weeks [24].
-
Group 4 (DEN + Fe3O4/Cs): Rats were received DEN orally as group 2 then treated with Fe3O4/Cs as group 3.
Rats were obtained from the National Centre for Radiation Research and Technology (NCCRT), Cairo, Egypt. The rats were housed in cages and maintained a 12-h light/dark cycle. They were allowed to acclimatize to the environmental conditions for 1 week before starting the experiment and were kept on standard food pellets containing all nutritive elements and liberal water ad libitum. All the ethical protocols for animal treatment were approved by the Ethical Committee at the National Center for Radiation Research and Technology (no: 3 A/ 22).
After the last dose of Fe3O4/Cs administration, rats were fasted overnight. Blood samples were withdrawn from the heart of each animal, under light anesthesia by diethyl ether. Blood was allowed to coagulate and then was centrifuged at 3000 rpm for 15 min, and the serum was separated in another tube. Immediately after blood sampling, animals were sacrificed by cervical dislocation; liver tissues were rapidly removed, washed in ice-cold saline, plotted to dry, and then were kept at − 80 °C till the day of analysis. Another part of liver tissue was placed in 10% formalin prepared in phosphate buffered saline (PBS) to be used for histopathological examination.
Molecular Investigation
Western Immunoblotting Analysis of PI3K/AKT/ mTOR and MAPK (P38, ERK1/2 and JNK) Proteins in Liver Tissue Homogenate
Liver tissue protein was extracted using TRIzol reagent, and protein concentration was quantified according to Bradford [25]. Twenty microgram of protein per lane was separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) using 10% acrylamide gels and transferred on to PVDA membranes. Membranes were incubated at room temperature for 2 h with blocking solution (5% non-fat dried milk in 10 mMTris-HCl, pH 7.5, 100 mMNaCl, and 0.1% Tween 20) and then incubated overnight at 4 °C with primary antibody towards targeted proteins with β-actin as a control. After washing three times in washing buffer (10 mMTris-HCL, pH 7.5, 100 mMNaCl, and 0.1% Tween 20), membrane was incubated with the secondary monoclonal antibody conjugated to horseradish peroxidase at room temperature for 2 h, and then membranes were washed four times with the same washing buffer. Membrane was developed and visualized by chemiluminescence using Invitrogen™ detection kit (Catalog #AHO1202) according to the manufacturer’s protocols and then exposed to X-ray film. Quantification of PI3K/AKT/ mTOR and MAPK (P38, ERK1/2 and JNK) proteins was carried out using scanning laser densitometer (Biomed Instrument Inc., USA).
Determination of Toll-Like Receptor 4 (TLR4) and Inducible Nitric Oxide Synthase (iNOS) Gene Expression
Total RNA was extracted from liver tissue using RNeasy Mini Kit (Qiagen, Cat. No. 74104) according to the manufacturer’s instructions. First strand complementary DNA (cDNA) synthesis was performed using QuantiTect Reverse Transcription Kit (Qiagen, Cat. No. 205311) according to the manufacturer’s instructions using 1 μg RNA as a template. RT-PCR were performed in a thermal cycler step one plus (Applied Biosystems, USA) using the Sequence Detection Software (PE Biosystems, CA). The oligonucleotides utilized in these experiments are listed in Table 1. The reaction mixture of total volume 25 μl was consisting of 2X SYBR Green PCR Master Mix (Qiagen, Cat. No. 204143), 900 nM of each primer and 2 μL of cDNA. PCR thermal-cycling conditions included an initial step at 95 °C for 5 min; 40 cycles at 95 °C for 20 s, annealing at 52 °C or 57 °C or 60 °C (as in Table 1) for 30 s, and 72 °C for 30 s. The relative expression of the real-time reverse transcriptase PCR products was determined by the ΔΔCt method. This method calculates a relative expression to housekeeping gene using the equation: fold induction = 2−(ΔΔCt), where ΔΔ Ct = Ct [gene of interest (unknown sample)—Ct housekeeping gene (unknown sample)]—[Ct gene of interest (calibrator sample)—Ct housekeeping gene (calibrator sample)] [26].
Biochemical Investigation
Tumor necrosis factor alpha (TNF-α) and cleaved caspase-3 were measured in liver tissue homogenates, according to the manufacturer’s instructions using ELISA kits supplied by MyBioSource, Inc. P.O. Box 153,308 San Diego, CA 92,195–3308, USA, while alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT) activities were analyzed in serum using commercial kits provided by Spinreact (Spain).
Histopathological Examination
Liver tissue specimens were fixed in 10% formol saline, then trimmed off, and washed and dehydrated in ascending grades of alcohol. The dehydrated specimens were then cleared in xylene, embedded in paraffin blocks, and sectioned at 4–6 µm thick. The obtained tissue sections were deparaffinized using xylol and stained using hematoxylin and eosin (H&E) for histopathological examination through the electric light microscope [27].
Histological Grade of Hepatocellular Carcinoma
The most widely used grading system in HCC (Edmondson and Steiner system). Grade I consists of small tumor cells, arranged in trabeculae, with abundant cytoplasm and minimal nuclear irregularity that are almost indistinguishable from normal liver tissue. Grade II tumors have prominent nucleoli, hyperchromatism, and some degree of nuclear irregularity. Grade III tumors show more pleomorphism than grade II and have angulated nuclei. Grade IV tumors have prominent pleomorphism and often anaplastic giant cells.
The pathological response of HCC to therapy was graded as Galal et al. (2013) [28].
Grade | Pathological response |
---|---|
Complete | 100% tumor necrosis |
Partial | 51–99% tumor necrosis |
Poor | < 50% tumor necrosis |
Statistical Analysis
The data were presented as means ± standard error of mean (S.E.); they were analyzed using one-way ANOVA followed by Tukey–Kramer multiple comparison test. The Graph Prism software, version 5, Inc., USA, was used to perform the statistical analysis and graphical presentations. The level of significance was fixed at P ≤ 0.05 with respect to all statistical tests.
Results
Characterization of Fe 3 O 4 /Cs
Transmission Electron Microscopy (TEM)
Figure 1 depicts a typical TEM micrograph of Fe3O4/chitosan nanoparticles. Because chitosan inhibits nanoparticle aggregation and consequently helped in uniform dispersion of the nanoparticles, Fe3O4/chitosan nanoparticles showed virtually little dispersion, with a mean diameter of about 9.95 nm. This might be due to the reaction taking place exclusively on the surface of the particle, and hence the attempt to make monodispersed Fe3O4/chitosan nanoparticles in this study was successful.
The X-Ray Diffraction (XRD)
Figure 2 shows the XRD of Fe3O4/Cs, which confirms the formation of Fe3O4/Chitosan nanoparticles through appearance of the characteristic peaks related to Fe3O4 nanoparticles at 2-Theta: 35 °C, 42 °C, 58, and 63. The appearance of the broad peak in the 2-Theta range 20–30° is related to the polymeric part of chitosan. Also, the coating of magnetic nanoparticles with chitosan chains causes a noticeable change in the XRD base line of Fe3O4 NPs (Fig. 2).
The Median Lethal Dose (LD50) of Fe3O4/Cs
The results revealed that the LD50 was found to be 500 mg/kg body weight for the Fe3O4/Cs for the intraperitoneal administration (Table 2). One-tenth of the LD50 value has been used as an ideal dose to determine the in vivo antitumor activity of Fe3O4/Cs.
Molecular and Biochemical Studies
The Effect of Fe 3 O 4 /Cs on PI3K/AKT/ mTOR and MAPK (P38, ERK1/2 and JNK) Pathways
Treatment with DEN manifested a significant (P ≤ 0.05) increase in the expression of the PI3K, AKT, and mTOR signal pathways (PI3K, 4.2-fold; AKT, 1.9-fold; and mTOR, 3.7-fold in respect to normal control). Treatment with Fe3O4/Cs induces a remarkable reduction in the expression of (PI3K, − 0.54-fold; AKT, − 0.57-fold; and mTOR, − 0.53-fold in respect to DEN) as shown in Table 3.
Moreover, protein expression of the mitogen-activated protein kinase (MAPK) family members shows a significant (P ≤ 0.05) increase (p38 MAPK, 4.08-fold; ERK1/2, 3.88-fold; JNK, 2.51-fold in DEN-treated rats in respect to normal control). Treatment with Fe3O4/Cs for DEN + Fe3O4/Cs group induces a remarkable reduction in these proteins (p38 MAPK, − 0.59-fold; ERK1/2, − 0.29-fold; JNK, − 0.64-fold in respect to DEN group) as shown in Table 3 and Fig. 3.
The Effect of Fe3O4/Cs on TLR4, iNOS, TNF-α, and Cleaved Caspase-3
The evaluation for the anti-inflammatory activity of Fe3O4/Cs was shown in Fig. 4; the data revealed a high significant (P ≤ 0.05) increase in the levels of the inflammatory biomarkers, TLR4 and iNOS (5.01-fold and 4.83-fold), respectively, in DEN-treated rats as compared to the corresponding control. In addition, the data displayed a high significant (P ≤ 0.05) increase in the levels of TNF-α (3.57-fold) with significant decrease in cleaved caspase-3 activity (− 0.76-fold) in DEN-treated rats as compared to the corresponding control. Meanwhile, the data displayed a dramatic decrease in (TLR4, − 0.56-fold; iNOS, − 0.76-fold; TNF-α, − 0.51-fold) with significant increase in the cleaved caspase-3 activity (5.1-fold) for Fe3O4/Cs + DEN treatment group as compare to DEN group.
The Effect of Fe3O4/Cs on Liver Function Biomarkers
The levels of ALT, AST, and GGT in the serum of all groups were examined to see if Fe3O4/Cs had any influence on liver function biomarkers. As shown in Fig. 5, DEN treatment caused severe liver injury, as evidenced by a significant (P ≤ 0.05) increase in serum (ALT, 3.2-fold; AST, 0.73-fold; and GGT, 6.5-fold for DEN group vs. control group), which was mitigated by Fe3O4/Cs treatment (ALT, − 0.46-fold; AST, − 0.12-fold; and GGT, − 0.73-fold for Fe3O4/Cs + DEN group vs. DEN group.
Histopathological Observation.
Light microscopic observation for control group demonstrated control hepatic tissue included normal polygonal cells with noticeable round nuclei and eosinophilic cytoplasm, as well as a few spaced hepatic sinusoids distributed in between the hepatic cords with fine Kupffer cell arrangement (Fig. 6a−b). Animals group treated with (Fe3O4/Cs) only showed normal histological picture similar to normal control group without any pathological alterations (Fig. 6c−d).
Histopathological alterations of liver tissue sections of hepatocellular carcinoma-induced rat group by (DEN) revealed polyhedral to round hepatocytes with dense, centrally located vesicular nuclei. The neoplastic areas showed poorly differentiated large cells with hyperchromatic nuclei and prominent nucleoli. The neoplastic cells showed pleomorphism, deeply basophilic scanty cytoplasm, and few mitotic figures (grade II). The hepatic lobule displayed disorganization of hepatic cords with hyperplasia of Kupffer cells (Fig. 6e−f).
Carcinogenic animals group treated by (Fe3O4/Cs) revealed necrobiotic changes of hepatic carcinoma cells with hyperplasia of Kupffer cells. Partial 51–99% tumor necrosis was noticed. Apoptosis and deeply eosinophilic cytoplasm without obvious mitotic figures were seen. Disorganization of carcinoma cells with widening of hepatic sinusoids were notice. Leukocytic infiltration mainly lymphocytes and macrophages were seen. Numerous numbers of binucleated cells and karyomegaly with peripheral condensation of its chromatin were noticed (Fig. 6g−h).
Discussion
HCC is a worldwide issue. HCCis the sixth common cancer worldwide, while it is fourth common cancer in Egypt. Egypt is Africa’s third and the world’s 15th most populous country, for HCC [29]. Iron oxide nanoparticles possess hopes in nanomedicine because of their potential use in cancer therapy, drug transport, and bioimaging [30]. Because Fe3O4 nanoparticles are easy to combine and oxidize, they are frequently coated to achieve better characteristics for targeted drug/gene delivery [7]. In view of these considerations the aim of the current study was to prepare and evaluate the efficacy of Fe3O4/Cs as an anticancer agent.
Fe3O4/Cs were prepared by exposure to 20 kGy gamma radiation then characterized using TEM and XRD. Gamma radiation is favored method for metallic nanoparticles synthesis because it is reproducible, simple, inexpensive, and uses fewer toxic precursors, as well as may control the yield shape of the monodispersed metallic nanoparticles [31]. Prepared Fe3O4/Cs showed a typical TEM micrograph for monodispersed Fe3O4/chitosan nanoparticles as chitosan inhibited the aggregation of nanoparticles. XRD showed characteristic peaks related to Fe3O4 nanoparticles (at 2-Theta: 35 °C, 42 °C, 58, and 63) and broad peak (in the 2-Theta range 20–30°) in related to the polymeric part of chitosan. The peak positions were unchanged, which illustrated that the chitosan binding process did not result in the phase change of Fe3O4 [32]. Prepared Fe3O4/Cs were evaluated as anticancer agent for HCC DEN-induced rats, where PI3K/Akt/mTOR and MAPK (ERK, JNK, P38) signaling pathways were studied, as well as inflammatory markers (TLR4, iNOS and TNF-α), cleaved caspase-3, and liver enzyme (ALT, AST and GGT) activities.
The PI3K/AKT/mammalian target of rapamycin (mTOR) signalling pathway is one of the most essential intracellular pathways, and it can be regarded a key regulator for cancer [33]. PI3K/AKT/mTOR pathway activation leads to tumor growth and anticancer drug resistance [34]. Growth factors activate the PI3K/Akt/mTOR pathway by connecting to their receptors and activating the substrates of the receptors. The phosphoinositide 3-kinase (PI3K) then binds to the active receptor’s intracellular part and transforms phosphatidylinositiol-4, 5-phosphate (PIP2) to phosphatidylinositiol-3, 4, 5-phosphate (PIP3). PIP3 then stimulates the PDK1 to AKT pathway, causing mTOR to be activated [35]. PI3K/Akt/mTOR and MAPK are more frequently activated intracellular pathways and the best characterized in HCC. Possibly playing a role in its pathogenesis [36]. In the current study, the DEN-challenged group had higher levels of PI3K/Akt/mTOR and MAPK pathway expression. Previous studies had found similar findings [37, 38]. Nanoparticle-based mTOR targeted therapy appears to be a promising treatment option for a variety of malignancies [39]. It’s worth mentioning that a large number of studies suggests that different NPs control mTOR activation, causing cell cycle arrest in cancerous cells [40], which simultaneously has an effect on the related signaling pathways AMPK and ERK. It is also worth noting that NP-mediated autophagy is correlated to the production of reactive oxygen species (ROS), which suppresses the mTOR pathway [41]. The Fe3O4 nanoparticles inhibited the mTOR phosphorylation [42] and AKT [43]. In the present study, Fe3O4/Cs modulated diethylnitrosamine (DEN)-induced HCCin animals models via PI3K/Akt/mTOR and MAPK (ERK, JNK, and P38) Signaling pathways. Such results were reported by the previous studies [41, 42, 44].
Toll-like receptor (TLR-4) appears to have a role in hepatocarcinogenesis, as TLR-4 expression increased as chronic hepatitis progressed to cirrhosis and then to HCC. TLR-4 expression was associated to a larger tumor size and a higher HCC grade, suggesting that it could be used to predict HCC prognosis. TLR-4 expression was found to be significantly higher in the DEN-treated group in the current investigation. Prior studies reported similar findings [45]. The effectiveness of metal oxide nanoparticles for TLRs varies depending on the metal type. Iron oxide nanoparticles (IONPs) differentially modulate TLR ligand-induced cytokine levels. The interactions between IONPs and TLR ligands are complicated and vary depending on the TLR ligand, nanoparticle size, and interactions between nanoparticles and TLR ligands [46]. Downstream TLR signaling causes MAPK cascades activation [47]. When these pathways are activated, macrophages undergo metabolic and functional changes, including differential expression of pro-inflammatory cytokines like tumor necrosis factor (TNF-α) [48]. In the current study, we observed upregulation in iNOS expression and increasing in TNF-α level in rats treated with DEN. Such results agree with the previous study done by Fathy and Nikaido, (2013) [49]. Metal oxide nanoparticles have been reported to induce both immunosuppressive and anti-inflammatory responses [50, 51]. According to the current findings, Fe3O4/Cs modulated the TLR4 activation. Also, Fe3O4/Cs treatment causes significant decreases in TNF-α level and downregulation in the expression of iNOS. Such results were reported by previous studies [46, 50, 52, 53].
Caspase-3 is a key molecule in cancer cell death. The active form of caspase-3, cleaved caspase-3, was the major cleavage enzyme that promoted apoptosis [54]. In the present study, we observed inhibition in cleaved caspase-3 activity in rats treated with DEN, which agree with the results reported by Lin et al. (2017) [55]. Fe3O4 nanoparticles induce apoptosis in cancer cells by raising the quantity of reactive oxygen species (ROS) and intracellular calcium, as well as boosting the expression of caspase-3 and caspase-9 and decreasing the expression of Bcl-2, as well as causing direct DNA damage [56]. The expression of cleaved caspase-3 is increased by the Fe3O4/Cs in the current study. Previous investigations had reported similar findings [57, 58].
Cytoplasmic transaminases, including ALT and AST, are released and circulated in response to DEN stimulation. Both ALT and AST are useful diagnostic markers for liver damage [59]. The data showed that the activities of ALT, AST, and GGT increased significantly, indicating that the DEN-induced HCC model was successfully constructed, as reported by the previous studies [37, 60, 61]. The present study demonstrated that Fe3O4/Cs treatment causes significant decreases in ALT, AST, and GGT levels. Also, inflammation response and pathological changes were alleviated by Fe3O4/Cs. Such results come in agreement with the previous studies [42, 62].
The present study concluded that administration of Fe3O4/Cs effectively inhibited the phosphorylations of PI3K/Akt/mTOR pathway and modulated P38, ERK, and JNK pathways. Moreover, it causes apoptosis in cancer cells by increasing the expression of cleaved caspase-3 and induces immunosuppression for cytokines. In addition, the inflammation response and pathological changes were alleviated by Fe3O4/Cs.
Data Availability
The data presented in this study are available in this article.
References
Wang SZ, Lee SD, Sarkar D, Lee HM, Khan A, Bhati C, Levy MF (2021) Immunological characterization of hepatocellular carcinoma. Hepatoma Res 7
Kim DW, Talati C, Kim R (2017) Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy. J Gastrointest Oncol 8(2):256
Singh K, Bhori M, Kasu YA, Bhat G, Marar T (2018) Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity–exploring the armoury of obscurity. Saudi Pharm J 26(2):177–190
Cordani M, Somoza Á (2019) Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment. Cell Mol Life Sci 76(7):1215–1242
Xia L, Wang Y, Chen Y, Yan J, Hao F, Su X, Xu M (2017) Cuprous oxide nanoparticles inhibit the growth of cervical carcinoma by inducing autophagy. Oncotarget 8(37):61083
Blanco J, Tomás-Hernández S, García T, Mulero M, Gómez M, Domingo JL, Sánchez DJ (2018) Oral exposure to silver nanoparticles increases oxidative stress markers in the liver of male rats and deregulates the insulin signalling pathway and p53 and cleaved caspase 3 protein expression. Food Chem Toxicol 115:398–404
Shen T, Zhu W, Yang L, Liu L, Jin R, Duan J, Ai H (2018) Lactosylated N-Alkyl polyethylenimine coated iron oxide nanoparticles induced autophagy in mouse dendritic cells. Regen Biomater 5(3):141–149
Chandrasekharan P, Tay ZW, Hensley D, Zhou XY, Fung BK, Colson C, Conolly S (2020) Using magnetic particle imaging systems to localize and guide magnetic hyperthermia treatment: tracers, hardware, and future medical applications. Theranostics 10(7):2965
Hernández-Hernández AA, Aguirre-Álvarez G, Cariño-Cortés R, Mendoza-Huizar LH, Jiménez-Alvarado R (2020) Iron oxide nanoparticles: synthesis, functionalization, and applications in diagnosis and treatment of cancer. Chem Pap 74:3809–3824
Reddy LH, Arias JL, Nicolas J, Couvreur P (2012) Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 112(11):5818–5878
Sang M, Luo R, Bai Y, Dou J, Zhang Z, Liu F, Liu W (2019) Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer. Theranostics 9(21):6209
Alkhader E, Billa N, Roberts CJ (2017) Mucoadhesive chitosan-pectinate nanoparticles for the delivery of curcumin to the colon. AAPS PharmSciTech 18(4):1009–1018
R Kamath P, Sunil D (2017) Nano-chitosan particles in anticancer drug delivery: an up-to-date review. Mini Rev Med Chem 17(15):1457–1487
Ramasamy T, Tran TH, Cho HJ, Kim JH, Kim YI, Jeon JY, Kim JO (2014) Chitosan-based polyelectrolyte complexes as potential nanoparticulate carriers: physicochemical and biological characterization. Pharm Res 31(5):1302–1314
Ramasamy T, Haidar ZS, Tran TH, Choi JY, Jeong JH, Shin BS, Kim JO (2014) Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs. Acta Biomater 10(12):5116–5127
Bharathi D, Ranjithkumar R, Vasantharaj S, Chandarshekar B, Bhuvaneshwari V (2019) Synthesis and characterization of chitosan/iron oxide nanocomposite for biomedical applications. Int J Biol Macromol 132:880–887
Kim YC, Guan KL (2015) mTOR: a pharmacologic target for autophagy regulation. J Clin Investig 125(1):25–32
Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Mizushima N (2009) Nutrient-dependent mTORC1 association with the ULK1–Atg13–FIP200 complex required for autophagy. Mol Biol Cell 20(7):1981–1991
Wang C, Cigliano A, Delogu S, Armbruster J, Dombrowski F, Evert M, Calvisi D (2013) Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: implications for the treatment of human liver cancer. Cell Cycle 12(13):1999–2010
Li L, Li L, Zhou X, Yu Y, Li Z, Zuo D, Wu Y (2019) Silver nanoparticles induce protective autophagy via Ca2+/CaMKKβ/AMPK/mTOR pathway in SH-SY5Y cells and rat brains. Nanotoxicology 13(3):369–391
Zeinali S, Nasirimoghaddam S, Sabbaghi S (2016) Investigation of the synthesis of chitosan coated iron oxide nanoparticles under different experimental conditions. Int J Nanosci Nanotechnol 12(3):183–190
Wilbrandt W (1952) Behrens methods for calculation of LD50. Arzneimittelforschung 2(11):501–503
Darwish HA, El-Boghdady NA (2013) Possible involvement of oxidative stress in diethylnitrosamine-induced hepatocarcinogenesis: chemopreventive effect of curcumin. J Food Biochem 37(3):353–361
Khedri B, Shahanipour K, Fatahian S, Jafary F (2018) Preparation of chitosan-coated Fe3O4 nanoparticles and assessment of their effects on enzymatic antioxidant system as well as high-density lipoprotein/low-density lipoprotein lipoproteins on wistar rat. Biomed Biotechnol Res J (BBRJ) 2(1):68
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72(1–2):248–254
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 25(4) 402–408
Bancroft JD, Stevens A, Turner DR (2013) Theory and practice of histological techniques, 4th edn. Churchill, Livingston, New York, London, San Francisco, Tokyo
El-Gazzaz G, Sourianarayanane A, Menon KN, Sanabria J, Hashimoto K, Quintini C, Aucejo F (2013) Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. Hepatobiliary Pancreat Dis Int 12(1):34–41
Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S (2020) Hepatocellular carcinoma (HCC) in Egypt: a comprehensive overview. J Egypt Natl Canc Inst 32(1):1–11
Geppert M, Himly M (2021) Iron oxide nanoparticles in bioimaging–an immune perspective. Front Immunol 12
Cele T (2020) Preparation of nanoparticles. Eng Nanomater-Health Saf IntechOpen
Unsoy G, Yalcin S, Khodadust R, Gunduz G, Gunduz U (2012) Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications. J Nanopart Res 14(11):1–13
Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X (2019) Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer 18(1):1–28
Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E (2014) PI3K/AKT signaling pathway and cancer: an updated review. Ann Med 46(6):372–383
Geissler EK, Schlitt HJ, Thomas G (2008) mTOR, cancer and transplantation. Am J Transplant 8(11):2212–2218
Finn RS (2013) Emerging targeted strategies in advanced hepatocellular carcinoma. Sem Liver Dis 33 S 01 S11-S19 Thieme Medical Publishers
Guoyin Z, Hao P, Min L, Wei G, Zhe C, Changquan L (2017) Antihepatocarcinoma effect of Portulaca oleracea L. in mice by PI3K/Akt/mTOR and Nrf2/HO-1/NF-κB pathway. Evid-Based Complement Alternat Med 2017
Younis NS, Ghanim AM, Saber S (2019) Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma. Sci Rep 9(1):1–16
Lunova M, Smolková B, Lynnyk A, Uzhytchak M, Jirsa M, Kubinová Š, Lunov O (2019) Targeting the mTOR signaling pathway utilizing nanoparticles: a critical overview. Cancers 11(1):82
Chiu HW, Xia T, Lee YH, Chen CW, Tsai JC, Wang YJ (2015) Cationic polystyrene nanospheres induce autophagic cell death through the induction of endoplasmic reticulum stress. Nanoscale 7(2):736–746
Jia L, Hao SL, Yang WX (2020) Nanoparticles induce autophagy via mTOR pathway inhibition and reactive oxygen species generation. Nanomedicine 15(14):1419–1435
Shen Y, Xiao Y, Zhang S, Wu S, Gao L, Shi S (2020) Fe3O4 nanoparticles attenuated Salmonella infection in chicken liver through reactive oxygen and autophagy via PI3K/Akt/mTOR signaling. Front Physiol 10:1580
Shetake NG, Kumar A, Gaikwad S, Ray P, Desai S, Ningthoujam RS, Pandey BN (2015) Magnetic nanoparticle-mediated hyperthermia therapy induces tumour growth inhibition by apoptosis and Hsp90/AKT modulation. Int J Hyperth 31(8):909–919
Park EJ, Umh HN, Kim SW, Cho MH, Kim JH, Kim Y (2014) ERK pathway is activated in bare-FeNPs-induced autophagy. Arch Toxicol 88(2):323–336
El-Gendy E, Zakaria R, Abd Elsamee T, Agina H, El Badawy R (2021) Significance of toll-like receptor 4 (TLR4) & liver fatty acid-binding protein (L-FABP) expression in hepatocellular carcinoma an immunohistochemical study. Benha Med J 38(Academic issue):92–111
Wolf-Grosse S, Mollnes TE, Ali S, Stenvik J, Nilsen AM (2018) Iron oxide nanoparticles enhance toll-like receptor-induced cytokines in a particle size-and actin-dependent manner in human blood. Nanomedicine 13(14):1773–1785
Roy R, Singh SK, Das M, Tripathi A, Dwivedi PD (2014) Toll-like receptor 6 mediated inflammatory and functional responses of zinc oxide nanoparticles primed macrophages. Immunology 142(3):453–464
Poon WL, Alenius H, Ndika J, Fortino V, Kolhinen V, Meščeriakovas A, Karisola P (2017) Nano-sized zinc oxide and silver, but not titanium dioxide, induce innate and adaptive immunity and antiviral response in differentiated THP-1 cells. Nanotoxicology 11(7):936–951
Fathy M, Nikaido T (2013) In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa. Environ Health Prev Med 18(5):377–385
Shen CC, Liang HJ, Wang CC, Liao MH, Jan TR (2012) Iron oxide nanoparticles suppressed T helper 1 cell-mediated immunity in a murine model of delayed-type hypersensitivity. Int J Nanomed 7:2729
Ngobili TA, Daniele MA (2016) Nanoparticles and direct immunosuppression. Exp Biol Med 241(10):1064–1073
Grosse S, Stenvik J, Nilsen AM (2016) Iron oxide nanoparticles modulate lipopolysaccharide-induced inflammatory responses in primary human monocytes. Int J Nanomed 11:4625
Líšková S, Bališ P, Mičurová A, Kluknavský M, Okuliarová M, Puzserová A, Bernátová I (2020) Effect of iron oxide nanoparticles on vascular function and nitric oxide production in acute stress-exposed rats. Physiol Res 69(6)
Asselin E, Mills GB, Tsang BK (2001) XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Can Res 61(5):1862–1868
Lin B, Zhu M, Wang W, Li W, Dong X, Chen Y, Li M (2017) Structural basis for alpha fetoprotein-mediated inhibition of caspase-3 activity in hepatocellular carcinoma cells. Int J Cancer 141(7):1413–1421
Ranjbary AG, Saleh GK, Azimi M (2021) Superparamagnetic iron oxide nanoparticles induce apoptosis in HT-29 cells by increasing ROS and damaging DNA
Chauhan A, Kumar R, Singh P, Jha SK, Kuanr BK (2020) RF hyperthermia by encapsulated Fe3O4 nanoparticles induces cancer cell death via time-dependent caspase-3 activation. Nanomedicine 15(04):355–379
Kasai S, Shimizu S, Tatara Y, Mimura J, Itoh K (2020) Regulation of Nrf2 by mitochondrial reactive oxygen species in physiology and pathology. Biomolecules 10(2):320
Chen T, Gao J, Xiang P, Chen Y, Ji J, Xie P, Yan T (2015) Protective effect of platycodin D on liver injury in alloxan-induced diabetic mice via regulation of Treg/Th17 balance. Int Immunopharmacol 26(2):338–348
Latief U, Husain H, Mukherjee D, Ahmad R (2016) Hepatoprotective efficacy of gallic acid during nitrosodiethylamine-induced liver inflammation in Wistar rats. J Basic Appl Zool 76:31–41
Liao S, Liu J, Xu M, Zheng J (2018) Evaluation of the liver cancer prevention of anthocyanin extracts from mulberry (Morus alba L.) variety PR-01. Adv Biosci Biotechnol 9(09):423
Ren Z, Chen X, Hong L, Zhao X, Cui G, Li A, Chen X (2020) Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis. Small 16(2):1905233
Acknowledgements
We wish to thank Dr. Faten Ismail Abou El Fadl, Associate Professor of Polymer chemistry, Polymer Chemistry Department, National Center for Radiation Research and Technology, (NCRRT), Egyptian Atomic Energy Authority (EAEA), who helped us during preparation and characterization of chitosan-coated iron oxide nanocomposite (Fe3O4/Cs).
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
All the ethical protocols for animal treatment were approved by the Ethical Committee at the National Center for Radiation Research and Technology (no: 3 A/ 22).
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Badawy, M.M.M., Abdel-Hamid, G.R. & Mohamed, H.E. Antitumor Activity of Chitosan-Coated Iron Oxide Nanocomposite Against Hepatocellular Carcinoma in Animal Models. Biol Trace Elem Res 201, 1274–1285 (2023). https://doi.org/10.1007/s12011-022-03221-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-022-03221-7